Edition:
United Kingdom

Assembly Biosciences Inc (ASMB.OQ)

ASMB.OQ on NASDAQ Stock Exchange Capital Market

36.55USD
17 Aug 2018
Change (% chg)

$-0.17 (-0.46%)
Prev Close
$36.72
Open
$36.60
Day's High
$36.89
Day's Low
$35.72
Volume
69,810
Avg. Vol
79,881
52-wk High
$66.89
52-wk Low
$24.30

Chart for

About

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $613.14
Shares Outstanding(Mil.): 17.36
Dividend: --
Yield (%): --

Financials

  ASMB.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.93 -- --
ROI: -45.44 15.07 14.61
ROE: -64.48 16.59 16.33

BRIEF-Assembly Biosciences Q1 Loss Per Share $0.80

* ASSEMBLY BIOSCIENCES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

07 May 2018

BRIEF-Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients

* ASSEMBLY BIOSCIENCES PRESENTS POSITIVE INTERIM DATA FROM PHASE 1A AND 1B STUDIES OF ABI-H0731 IN HBV PATIENTS IN A LATE-BREAKER SESSION AT THE EASL CONFERENCE

12 Apr 2018

BRIEF-Assembly Biosciences Says Graham Cooper Joined Assembly As New CFO And COO Effective March 8​

* ASSEMBLY BIOSCIENCES ANNOUNCES ADDITIONS TO MANAGEMENT TEAM AND BOARD OF DIRECTORS

12 Mar 2018

Competitors

  Price Chg
Kyowa Hakko Kirin Co Ltd (4151.T) ¥1,985 +79.00

Earnings vs. Estimates